GTCR Recapitalizes Cole-Parmer with Golden Gate Capital and Management
September 26, 2019
GTCR has signed a definitive agreement to recapitalize Cole-Parmer Instrument Company, acquiring a majority stake while Golden Gate Capital and CEO Bernd Brust with the Cole-Parmer management team retain significant minority ownership. The recapitalization will support Cole-Parmer's continued organic growth and strategic M&A in the life sciences, healthcare and environmental laboratory products markets; the company will remain headquartered in Vernon Hills, Illinois.
- Buyers
- GTCR, Golden Gate Capital, Bernd Brust and the Cole-Parmer management team
- Targets
- Cole-Parmer Instrument Company
- Sellers
- Golden Gate Capital
- Industry
- Medical Devices
- Location
- Illinois, United States
- Transaction Type
- Recapitalization
Explore More
Related Acquisitions
-
GTCR Invests $1.33 Billion in Tricentis
November 26, 2024
Software
GTCR has signed a definitive agreement to invest $1.33 billion in Tricentis, valuing the enterprise at $4.5 billion. Insight Partners will continue as a significant investor and will work with GTCR with equal board representation as Tricentis uses the capital to fuel growth, product innovation, and global expansion.
-
Golden Gate Capital Recapitalizes Parallel Advisors; Parallel Acquires AUTUS Asset Management
January 5, 2023
Wealth Management
Parallel Advisors completed a recapitalization led by its management team and Golden Gate Capital to accelerate organic growth and M&A. In connection with the investment, Parallel acquired AUTUS Asset Management, bringing the combined firm to approximately $5.7 billion in AUM, and prior minority investor Emigrant Partners fully exited.
-
GTCR Invests in Biocoat
November 2, 2022
Medical Devices
GTCR has made a strategic, majority recapitalization investment in Biocoat Holdings, LLC, a Horsham, Pennsylvania-based provider of biocompatible hydrophilic coatings and dip-coating equipment for medical devices. Existing investor 1315 Capital and Biocoat management retain minority stakes; GTCR will partner with CEO Jim Moran and add industry veteran Chip Hance as Executive Chairman to support growth, capability expansion and follow-on acquisitions.
-
Kohlberg & Company Recapitalizes Trinity Life Sciences
November 30, 2021
Healthcare Services
Kohlberg & Company will recapitalize Trinity Life Sciences, replacing Parthenon Capital as the company’s capital partner. The transaction provides Trinity with new growth capital to support global expansion, technology and data-driven capability investments while Trinity’s management team, led by CEO David Fitzhenry, will remain in place.
-
Cole-Parmer (GTCR Portfolio) Acquires ZeptoMetrix
January 12, 2021
Biotechnology
GTCR’s portfolio company Cole-Parmer has acquired ZeptoMetrix, a Buffalo-based developer and manufacturer of quality control standards and verification panels for molecular diagnostic testing. The acquisition expands Cole-Parmer’s life sciences quality controls and reference standards portfolio and strengthens its capabilities in infectious disease and molecular diagnostics.
-
Golden Gate Capital Acquires Majority Stake in Ensemble Health Partners
May 29, 2019
Healthcare Services
Golden Gate Capital has acquired a 51% equity stake in Ensemble Health Partners from Bon Secours Mercy Health, with Bon Secours remaining a minority owner and commercial partner. Ensemble, headquartered in Mason, Ohio, will continue to be led by its existing management team and will use the investment to expand technology, services and growth initiatives across its revenue cycle management operations (the company has ~3,600 employees).
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.